Friday, August 23, 2013 6:38:45 AM
The most common flu complications include viral or bacterial pneumonia, muscle inflammation (myositis), central nervous system disease, and heart problems including heart attacks, inflammation of the heart muscle (myocarditis), and inflammation of the sac around the heart (pericarditis).
Other flu complications may include ear infections and sinus infections, especially in children, dehydration, and worsening of chronic medical conditions, such as congestive heart failure, asthma, or diabetes.
Those at highest risk for flu complications include adults over 50, children ages 6 months to 4 years, nursing home residents, adults and children with heart or lung disease, people with compromised immune systems (including people with HIV/AIDS), and pregnant women.
(For in-depth information, see WebMD's Flu and Chronic Medical Conditions.)
source: http://www.webmd.com/cold-and-flu/flu-guide/flu-complications
The Inflammation-Heart Attack Connection: New Evidence
http://youtu.be/tP9vGs0Adzc
NanoViricides Reports Its Oral FluCide® Anti-Influenza Drug Candidates Are Superior to Oral Oseltamivir (TamiFlu®) in H1N1 Influenza Lethal Infection Model
The potential of an oral anti-influenza nanoviricide® drug has important implications for disease treatment. According to the CDC, influenza is a highly communicable acute respiratory disease that is considered to be one of the major infectious disease threats to the human population. During seasonal epidemics, 5-15% of the world population is typically infected (or about 300 million to 1 billion people infected), resulting in 3-5 million cases of severe illness affecting all age groups. Historically, in the USA alone, 5% to 20% of the population (approximately 40M people) come down with the flu annually, of which more than 200,000 persons are hospitalized from influenza-related complications, and approximately 36,000 people die from influenza-related causes even in a non-pandemic year. During the 1918 pandemic year, 675,000 Americans died from the flu. Most victims were healthy young adults and it was thought that majority of the deaths were from a phenomenon called “cytokine storm”, essentially an over-reaction of the immune system to the novel viral infection.
Read more: NanoViricides Reports Its Oral FluCide® Anti-Influenza Drug Candidates Are Superior to Oral Oseltamivir (TamiFlu®) in H1N1 Influenza Lethal Infection Model - FierceBiotech http://www.fiercebiotech.com/press-releases/nanoviricides-reports-its-oral-flucide-anti-influenza-drug-candidates-are-s#ixzz2cmh718QP
Subscribe at FierceBiotech
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM